Cargando…
P1533: TRIAL IN PROGRESS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PARSACLISIB IN PATIENTS WITH PRIMARY WARM AUTOIMMUNE HEMOLYTIC ANEMIA
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431322/ http://dx.doi.org/10.1097/01.HS9.0000848988.44172.ff |
| _version_ | 1784780022653911040 |
|---|---|
| author | Barcellini, W. Butler, K. Moran, S. Bibeau, K. Dzhindzhikhashvili, I. Wei, S. Jäger, U. |
| author_facet | Barcellini, W. Butler, K. Moran, S. Bibeau, K. Dzhindzhikhashvili, I. Wei, S. Jäger, U. |
| author_sort | Barcellini, W. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431322 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94313222022-08-31 P1533: TRIAL IN PROGRESS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PARSACLISIB IN PATIENTS WITH PRIMARY WARM AUTOIMMUNE HEMOLYTIC ANEMIA Barcellini, W. Butler, K. Moran, S. Bibeau, K. Dzhindzhikhashvili, I. Wei, S. Jäger, U. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431322/ http://dx.doi.org/10.1097/01.HS9.0000848988.44172.ff Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Barcellini, W. Butler, K. Moran, S. Bibeau, K. Dzhindzhikhashvili, I. Wei, S. Jäger, U. P1533: TRIAL IN PROGRESS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PARSACLISIB IN PATIENTS WITH PRIMARY WARM AUTOIMMUNE HEMOLYTIC ANEMIA |
| title | P1533: TRIAL IN PROGRESS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PARSACLISIB IN PATIENTS WITH PRIMARY WARM AUTOIMMUNE HEMOLYTIC ANEMIA |
| title_full | P1533: TRIAL IN PROGRESS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PARSACLISIB IN PATIENTS WITH PRIMARY WARM AUTOIMMUNE HEMOLYTIC ANEMIA |
| title_fullStr | P1533: TRIAL IN PROGRESS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PARSACLISIB IN PATIENTS WITH PRIMARY WARM AUTOIMMUNE HEMOLYTIC ANEMIA |
| title_full_unstemmed | P1533: TRIAL IN PROGRESS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PARSACLISIB IN PATIENTS WITH PRIMARY WARM AUTOIMMUNE HEMOLYTIC ANEMIA |
| title_short | P1533: TRIAL IN PROGRESS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PARSACLISIB IN PATIENTS WITH PRIMARY WARM AUTOIMMUNE HEMOLYTIC ANEMIA |
| title_sort | p1533: trial in progress: a randomized, double-blind, placebo-controlled phase 3 study of the efficacy and safety of parsaclisib in patients with primary warm autoimmune hemolytic anemia |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431322/ http://dx.doi.org/10.1097/01.HS9.0000848988.44172.ff |
| work_keys_str_mv | AT barcelliniw p1533trialinprogressarandomizeddoubleblindplacebocontrolledphase3studyoftheefficacyandsafetyofparsaclisibinpatientswithprimarywarmautoimmunehemolyticanemia AT butlerk p1533trialinprogressarandomizeddoubleblindplacebocontrolledphase3studyoftheefficacyandsafetyofparsaclisibinpatientswithprimarywarmautoimmunehemolyticanemia AT morans p1533trialinprogressarandomizeddoubleblindplacebocontrolledphase3studyoftheefficacyandsafetyofparsaclisibinpatientswithprimarywarmautoimmunehemolyticanemia AT bibeauk p1533trialinprogressarandomizeddoubleblindplacebocontrolledphase3studyoftheefficacyandsafetyofparsaclisibinpatientswithprimarywarmautoimmunehemolyticanemia AT dzhindzhikhashvilii p1533trialinprogressarandomizeddoubleblindplacebocontrolledphase3studyoftheefficacyandsafetyofparsaclisibinpatientswithprimarywarmautoimmunehemolyticanemia AT weis p1533trialinprogressarandomizeddoubleblindplacebocontrolledphase3studyoftheefficacyandsafetyofparsaclisibinpatientswithprimarywarmautoimmunehemolyticanemia AT jageru p1533trialinprogressarandomizeddoubleblindplacebocontrolledphase3studyoftheefficacyandsafetyofparsaclisibinpatientswithprimarywarmautoimmunehemolyticanemia |